TP53 and neoplasm: Statistical analysis of IHC score with clinicopathologic parameters showed that RyR2 expression was not correlated with tumor size (P = 0.114), P53 status (P = 0.279) or Ki67 status (P = 0.731), indicating that RyR2 expression did not affect tumor growth (Table S1).